🇺🇸 FDA
Patent

US 8357365

Granulysin peptides and methods of use thereof

granted A61KA61K2800/28A61K38/1709

Quick answer

US patent 8357365 (Granulysin peptides and methods of use thereof) held by The Regents of the University of California expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2800/28, A61K38/1709, A61K8/64